No problem. I'm very wary of wording changes. Also the fact that they don't appear to have a fixed agreement structure is a little concerning to me. It seems like MXC will supply product when it is needed which is a great deal for Cannaglobal but also means anticipating revenue will be quite difficult. It all comes full circle I guess as the bulk of the deal is for equity in Cannaglobal so if there was a fixed cost deal in place it could potentially bankrupt Cannaglobal and the equity would be worthless.
No sales of CannEpil until 2019 so it's hard to say what the next quarter will bring. With Cannabis demand so strong in Canada/US it would be great for Cannaglobal to take ownership of Derma sooner rather than later so that MXC can benefit from the transaction.
No problem. I'm very wary of wording changes. Also the fact that...
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 3022 | 4 |
View Market Depth
| Last trade - 16.12pm 28/06/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable